MIRM Reports 100% Virologic Response in 300mg QW Arm, 75% in 900mg Q4W, Phase 2b AZURE-1 Meets Primary Endpoint
Mirum Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $96.33
+4.2% since the alert
$92.48 → $96.33
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS